ALB and neoplasm: The baseline data, including gender, age, HBV infection status, max tumor size, portal vein invasion, extrahepatic metastasis, Child-Pugh class, BCLC stage and combination therapies, PLT, ALB, ALT, TBIL, PT, WBC, NEUT, MONO, AFP, NLR, PLR and MLR, did not show a statistically significant difference between the training set and the validation set.